Synbiotics Show Promise in Improving Diabetes Risk Factors
Recent research from the European Medical Journal highlights that synbiotic supplementation can significantly reduce diabetes risk factors, including weight, blood sugar, and cholesterol. This aligns with growing evidence that modulating gut microbiota offers a promising complementary strategy for managing metabolic health globally.
- Synbiotic supplementation led to significant weight and body fat reduction.
- Improved fasting plasma glucose and insulin resistance observed in studies.
- Beneficial effects on total cholesterol and LDL-C levels demonstrated.
- Modulating gut microbiome with synbiotics supports cardiometabolic health.
- Research corroborates synbiotics as an adjunct therapy for diabetes management.
Read the full story on Quick Digest.